Partner
Emir Sandhu
Managing Director, Blue Cross Blue Shield Venture Partners (+1 more)
- Firm
- Blue Cross Blue Shield Venture Partners, Sandbox Industries
- Title
- Managing Director
- Role
- Managing partner
- Known as
- Investor
Claim, correct or request removal
Record updated 17 September 2026
About
Dr. Emir Sandhu joined Sandbox Industries in 2019. He is a Partner of Sandbox Industries and a Managing Director at the Blue Venture Fund. He currently serves on the board of directors of Exai Bio, Somatus, Onc.AI, and Ultromics. He serves as a Board Observer of Noctrix and Octave Bioscience. He also supports or has supported the Blue Venture Fund's investments in Owl Health, Thrive Earlier Detection, PicassoMD, and HeartFlow. Dr. Sandhu focuses on investments from seed to buyout within healthcare services and medical technologies, including devices, diagnostics, and AI.
Background
- Expertise
- investments from seed to buyout within healthcare services and medical technologies, including devices, diagnostics, and AI
- Education
- Dr. Sandhu holds an MD from Harvard Medical School, an MBA from Harvard Business School and a BA in Economics from the University of North Carolina as a Morehead-Cain Scholar. He completed his radiology residency at Stanford University and Memorial Sloan Kettering Cancer Center.Source (opens in a new tab)
Is this you? Remove my profile
Loading relationship preview